These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8739255)

  • 21. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
    Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
    J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human heart failure: cAMP stimulation of SR Ca(2+)-ATPase activity and phosphorylation level of phospholamban.
    Schmidt U; Hajjar RJ; Kim CS; Lebeche D; Doye AA; Gwathmey JK
    Am J Physiol; 1999 Aug; 277(2):H474-80. PubMed ID: 10444471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of cardiac myocyte and tissue beta-adrenergic signal transduction in rats with heart failure.
    Yoshida H; Tanonaka K; Miyamoto Y; Abe T; Takahashi M; Anand-Srivastava MB; Takeo S
    Cardiovasc Res; 2001 Apr; 50(1):34-45. PubMed ID: 11282076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Of phospholamban, mice, and humans with heart failure.
    Bristow M
    Circulation; 2001 Feb; 103(6):787-8. PubMed ID: 11171783
    [No Abstract]   [Full Text] [Related]  

  • 26. Alteration of the beta-adrenergic signaling pathway in human heart failure.
    Hamdani N; Linke WA
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2522-31. PubMed ID: 22280427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.
    Irie T; Sips PY; Kai S; Kida K; Ikeda K; Hirai S; Moazzami K; Jiramongkolchai P; Bloch DB; Doulias PT; Armoundas AA; Kaneki M; Ischiropoulos H; Kranias E; Bloch KD; Stamler JS; Ichinose F
    Circ Res; 2015 Oct; 117(9):793-803. PubMed ID: 26259881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor crosstalk: effects of prolonged carbachol exposure on beta 1-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes.
    Paraschos A; Karliner JS
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):267-76. PubMed ID: 7824043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol.
    Gwathmey JK; Kim CS; Hajjar RJ; Khan F; DiSalvo TG; Matsumori A; Bristow MR
    Am J Physiol; 1999 May; 276(5):H1678-90. PubMed ID: 10330254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ser16 prevails over Thr17 phospholamban phosphorylation in the beta-adrenergic regulation of cardiac relaxation.
    Kuschel M; Karczewski P; Hempel P; Schlegel WP; Krause EG; Bartel S
    Am J Physiol; 1999 May; 276(5):H1625-33. PubMed ID: 10330247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application.
    Wachter SB; Gilbert EM
    Cardiology; 2012; 122(2):104-12. PubMed ID: 22759389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.
    Ren B; Shao Q; Ganguly PK; Tappia PS; Takeda N; Dhalla NS
    Can J Physiol Pharmacol; 2004 Dec; 82(12):1118-27. PubMed ID: 15644955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detrimental effects of beta-adrenergic stimulation on beta-adrenoceptors and microtubules in the heart.
    Hori M; Koretsune Y; Sato H; Kagiya T; Kitabatake A; Kamada T
    Heart Vessels Suppl; 1991; 6():11-7. PubMed ID: 1687922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.
    Ahmed A
    Eur J Heart Fail; 2003 Dec; 5(6):709-15. PubMed ID: 14675848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ouabain treatment is associated with upregulation of phosphatase inhibitor-1 and Na+/Ca(2+)-exchanger and beta-adrenergic sensitization in rat hearts.
    El-Armouche A; Jaeckel E; Boheler KR; Boknik P; Hertle B; Neumann J; Eschenhagen T
    Biochem Biophys Res Commun; 2004 May; 318(1):219-26. PubMed ID: 15110776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The beta-adrenergic receptor in heart failure.
    Heinsimer JA; Lefkowitz RJ
    Hosp Pract (Off Ed); 1983 Nov; 18(11):103-9, 113-7, 121-5. PubMed ID: 6138306
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the role of beta-adrenergic signaling in heart failure?
    Lohse MJ; Engelhardt S; Eschenhagen T
    Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.
    Horn EM; Corwin SJ; Steinberg SF; Chow YK; Neuberg GW; Cannon PJ; Powers ER; Bilezikian JP
    Circulation; 1988 Dec; 78(6):1373-9. PubMed ID: 2847884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.